Call Number (LC) | Title | Results |
---|---|---|
QP609.C4 I58 1983 | Cholinesterases, fundamental and applied aspects : proceedings of the Second International Meeting on Cholinesterases, Bled, Yugoslavia (September 17th to 21st, 1983) / | 1 |
QP609.C4 S67 1993 |
Human cholinesterases and anticholinesterases Human cholinesterases and anticholinesterases / |
2 |
QP609.C4 S77 1998 | Structure and function of cholinesterases and related proteins / | 1 |
QP609.C92 C92 1990 | Cyclic nucleotide phosphodiesterases : structure, regulation and drug action / | 1 |
QP609.C92 C93 2007 | Cyclic nucleotide phosphodiesterases in health and disease / | 1 |
QP609.C92 C93 2007eb | Cyclic nucleotide phosphodiesterases in health and disease | 1 |
QP609.C92 .P467 2014eb | Phosphodiesterases and their inhibitors / | 2 |
QP609.C93 | Cyclin dependent kinase (CDK) inhibitors : methods and protocols / | 1 |
QP609.C93 C93 2008 |
Cyclin dependent kinase 5 (Cdk5) / Cyclin dependent kinase 5 (Cdk5) |
3 |
QP609.C93 I54 2007 | Inhibitors of cyclin-dependent kinases as anti-tumor agents / | 1 |
QP609.C93 I54 2007eb | Inhibitors of cyclin-dependent kinases as anti-tumor agents | 1 |
QP609.C94 |
CCN proteins : methods and protocols / CD95 : methods and protocols / Caspases, paracaspases, and metacaspases : methods and protocols / |
4 |
QP609.C94 .C32 2017 | CD95 : methods and protocols / | 1 |
QP609.C94 .C36 2017 | CCN proteins : methods and protocols / | 1 |
QP609.C94 C37 2014 | Caspases, paracaspases, and metacaspases : methods and protocols / | 1 |
QP609.C94 C965 2011 | Cysteine proteases of pathogenic organisms | 1 |
QP609.C94 D47 2009eb | Design of caspase inhibitors as potential clinical agents | 1 |
QP609.C94 K57 1998 | Lysosomal cysteine proteases / | 1 |
QP609.D4 D63 2022 | DNAzymes : methods and protocols / | 1 |
QP609.D52 A44 1985 | Nutritional and toxicological significance of enzyme inhibitors in foods / | 1 |